摘要
通过分析药品研发周期风险因素,利用文献资料采取综述的方法,构建药品研发多向风险管理机制,从而提高新药研发的成功率,最大程度地降低医药企业承担的研发风险,使新药研发周期达到良性循环,将合作是多赢的风险管理战略理念应用于药品研发周期中,以增强药品研发管理机制的科学性与张力,进一步改善药品研发风险管理,保障公众用药安全。
By analyzing the risk factors for pharmaceutical R＆D cycle and summarizing the literature data, we constructed the mechanism of multi-directional risk management in order to improve the success rate of drug R＆D, minimize pharmaceutical R＆D risk for pharmaceutical companies, and achieve a virtuous cycle. The con- cept that cooperation is a win-win situation should he taken as a risk management strategy in pharmaceutical R＆D cycle in order to enhance the scientificity and tension of pharmaceutical R＆D management mechanism, further im- prove pharmaceutical R＆D risk management and ensure the safety of the public drug use.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2015年第7期737-740,共4页
Chinese Journal of New Drugs
基金
黑龙江省教育厅2013年度人文社会科学面上项目(12532215)
关键词
药品研发
研发周期
风险管理
合作
机制
pharmaceutical R＆D
R＆D cycle
risk management
cooperation
mechanism
